DK0689534T3 - Amidderivater som 5-HT1A-ligander - Google Patents
Amidderivater som 5-HT1A-liganderInfo
- Publication number
- DK0689534T3 DK0689534T3 DK94908456T DK94908456T DK0689534T3 DK 0689534 T3 DK0689534 T3 DK 0689534T3 DK 94908456 T DK94908456 T DK 94908456T DK 94908456 T DK94908456 T DK 94908456T DK 0689534 T3 DK0689534 T3 DK 0689534T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- date
- amide derivatives
- sec
- formula
- Prior art date
Links
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 title abstract 2
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 title abstract 2
- 150000001408 amides Chemical class 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 230000000949 anxiolytic effect Effects 0.000 abstract 1
- 229940005530 anxiolytics Drugs 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939305672A GB9305672D0 (en) | 1993-03-19 | 1993-03-19 | Amide derivatives |
| PCT/GB1994/000455 WO1994021611A1 (en) | 1993-03-19 | 1994-03-09 | Amide derivatives as 5-ht1a ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0689534T3 true DK0689534T3 (da) | 2003-02-03 |
Family
ID=10732342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94908456T DK0689534T3 (da) | 1993-03-19 | 1994-03-09 | Amidderivater som 5-HT1A-ligander |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5629323A (da) |
| EP (1) | EP0689534B1 (da) |
| JP (1) | JPH08507779A (da) |
| AT (1) | ATE225335T1 (da) |
| AU (1) | AU6149094A (da) |
| DE (1) | DE69431471T2 (da) |
| DK (1) | DK0689534T3 (da) |
| ES (1) | ES2181711T3 (da) |
| GB (1) | GB9305672D0 (da) |
| PH (1) | PH31589A (da) |
| PT (1) | PT689534E (da) |
| WO (1) | WO1994021611A1 (da) |
| ZA (1) | ZA941739B (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5541179A (en) * | 1995-05-02 | 1996-07-30 | American Home Products Corporation | Tropon-2-one piperazine carboxamides as serotonergic agents |
| US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
| US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
| US6906069B1 (en) | 1999-01-08 | 2005-06-14 | Amgen Inc. | LXR modulators |
| DK1035115T3 (da) | 1999-02-24 | 2005-01-24 | Hoffmann La Roche | 4-phenylpyridinderivater og anvendelse deraf som NK-1-receptorantagonister |
| AU2000235960A1 (en) * | 2000-02-14 | 2001-08-27 | Tularik, Inc. | Lxr modulators |
| US6673543B2 (en) | 2000-04-05 | 2004-01-06 | Tularik, Inc. | Solid phase synthesis of LXR ligands |
| US7112606B2 (en) | 2002-01-30 | 2006-09-26 | Amgen Inc. | Heterocyclic arylsulfonamidobenzylic compounds |
| TWI280239B (en) | 2003-07-15 | 2007-05-01 | Hoffmann La Roche | Process for preparation of pyridine derivatives |
| CA2623237C (en) | 2005-09-23 | 2013-07-09 | F. Hoffmann-La Roche Ag | Novel dosage formulation |
| US10316025B2 (en) | 2015-06-03 | 2019-06-11 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA855563B (en) * | 1984-07-30 | 1986-05-28 | Merrell Dow Pharma | Glutarimide antianxiety and antihypertensive agents |
| EP0367888A1 (en) * | 1988-11-08 | 1990-05-16 | ISTITUTO LUSO FARMACO D'ITALIA S.p.A. | 2,2-Disubstituted 2,3-dihydro-1,4-benzodioxin derivatives having hypotensive activity |
| GB9021535D0 (en) * | 1990-10-03 | 1990-11-14 | Wyeth John & Brother Ltd | Piperazine derivatives |
| IL101722A (en) * | 1991-05-02 | 1996-05-14 | Wyeth John & Brother Ltd | Piperazine derivatives their preparation and pharmaceutical compositions containing them |
-
1993
- 1993-03-19 GB GB939305672A patent/GB9305672D0/en active Pending
-
1994
- 1994-03-09 EP EP94908456A patent/EP0689534B1/en not_active Expired - Lifetime
- 1994-03-09 AU AU61490/94A patent/AU6149094A/en not_active Abandoned
- 1994-03-09 WO PCT/GB1994/000455 patent/WO1994021611A1/en not_active Ceased
- 1994-03-09 JP JP6520749A patent/JPH08507779A/ja not_active Withdrawn
- 1994-03-09 US US08/446,651 patent/US5629323A/en not_active Expired - Lifetime
- 1994-03-09 ES ES94908456T patent/ES2181711T3/es not_active Expired - Lifetime
- 1994-03-09 AT AT94908456T patent/ATE225335T1/de not_active IP Right Cessation
- 1994-03-09 PT PT94908456T patent/PT689534E/pt unknown
- 1994-03-09 DK DK94908456T patent/DK0689534T3/da active
- 1994-03-09 DE DE69431471T patent/DE69431471T2/de not_active Expired - Fee Related
- 1994-03-11 ZA ZA941739A patent/ZA941739B/xx unknown
- 1994-03-17 PH PH47940A patent/PH31589A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE225335T1 (de) | 2002-10-15 |
| ES2181711T3 (es) | 2003-03-01 |
| DE69431471T2 (de) | 2003-07-10 |
| GB9305672D0 (en) | 1993-05-05 |
| AU6149094A (en) | 1994-10-11 |
| DE69431471D1 (de) | 2002-11-07 |
| EP0689534A1 (en) | 1996-01-03 |
| ZA941739B (en) | 1995-09-11 |
| WO1994021611A1 (en) | 1994-09-29 |
| JPH08507779A (ja) | 1996-08-20 |
| PT689534E (pt) | 2003-01-31 |
| US5629323A (en) | 1997-05-13 |
| PH31589A (en) | 1998-11-03 |
| EP0689534B1 (en) | 2002-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9300194D0 (en) | Piperazine derivatives | |
| DK0689534T3 (da) | Amidderivater som 5-HT1A-ligander | |
| TW281673B (da) | ||
| DE59304311D1 (de) | N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika | |
| NZ291855A (en) | Bridged azabicyclo-piperazin-1-yl-2-phenyl-butan-1-one derivatives as 5-ht1a antagonists | |
| TW282458B (da) | ||
| ATE206127T1 (de) | Inhibitoren retroviraler proteasen | |
| TW289019B (da) |